CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Hakim, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Hakim, I. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 1472-1476, November 2002
© 2002 American Association for Cancer Research

Pharmacokinetics of Perillic Acid in Humans after a Single Dose Administration of a Citrus Preparation Rich in d-Limonene Content1

H-H. Sherry Chow2, Dawn Salazar and Iman A. Hakim

Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724

d-Limonene, a monoterpene, is widely distributed as a natural nonnutritive constituent of a variety of foods and volatile oils, particularly citrus oils. d-Limonene and its derived metabolites have been shown to possess cancer chemotherapeutic and chemopreventive efficacy in various preclinical model systems. In our previous work, we have found that lemonade prepared with the whole lemon (Mediterranean-style lemonade) contains high levels of d-limonene. The current study is designed to determine the systemic availability of perillic acid, a major and biologically active metabolite of d-limonene, after a single dose administration of Mediterranean-style lemonade. Healthy individuals were recruited to consume 30–40 oz of Mediterranean-style lemonade with a light breakfast. Blood samples were collected for up to 24 h after the completion of lemonade consumption. d-Limonene levels in the juice and perillic acid levels in plasma were determined by reversed-phase high-performance liquid chromatography with UV detection. It was found that 40 oz of lemonade contained 596 mg of d-limonene and 30 oz contained 447 mg of d-limonene. Plasma concentrations of perillic acid reached maximal levels at 1 h after the lemonade consumption and declined rapidly as a function of time with the terminal elimination half-life ranging from 0.82 to 1.84 h. The maximum plasma perillic acid concentration ranged from 2.08 to 13.98 µM, and the levels were undetectable at 24 h after the lemonade consumption. The area under the plasma concentration-time curves of perillic acid ranged from 5.07 to 32.59 (µM)·h. Our study illustrates that the major metabolite of d-limonene is bioavailable after oral consumption of a citrus preparation rich in d-limonene content.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. Mo and C. E. Elson
Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention
Experimental Biology and Medicine, July 1, 2004; 229(7): 567 - 585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.